Health
Pfizer-BioNTech COVID-19 Vaccine Achieves 100% Effectiveness in Adolescents – Contagionlive.com
The newest data for the real-world assessment show the mRNA vaccine provides greater immunogenicity in persons aged 12-15 years old than in young adults.
Pfizer-BioNTech COVID-19 vaccine BNT162b2 provided an observed vaccine efficacy of 100% among adolescents aged 12-15 years old after 7 days post-administration with the 2-dose product.
The new findings from an ongoing, placebo-controlled, observer-blinded assessment of the mRNA vaccine in adolescent patients suggest BNT162b2 provides an even greater immune response in the population than that observed in vaccinated young adults.
Led by Robert W. Frenck, Jr., MD, of the Cincinnati Childrens Hospital,…
-
Business24 hours agoWhy Amotiv, Breville, Life360, and Woodside shares are tumbling today
-
Noosa News22 hours agoDevastating update in search for missing Queensland mother Tayla Spies as police find human remains near her ute
-
Noosa News23 hours agoDingoes bite 3 women on K’gari
-
Noosa News15 hours agoBrisbane doctor jailed for trafficking ‘breathtaking amount’ of drugs